Serum biomarkers and risk of hepatocellular carcinoma recurrence after liver transplantation

Liver transplantation (LT) is the only potentially curative treatment for selected patients with cirrhosis and hepatocellular carcinoma (HCC) who are not candidates for resection. When the Milan criteria are strictly applied, 75% to 85%of 3- to 4-year actuarial survival rates are achieved, but up to...

Descripción completa

Detalles Bibliográficos
Autores principales: Citores, Maria J, Lucena, Jose L, de la Fuente, Sara, Cuervas-Mons, Valentin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354126/
https://www.ncbi.nlm.nih.gov/pubmed/30705718
http://dx.doi.org/10.4254/wjh.v11.i1.50

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354126/
https://www.ncbi.nlm.nih.gov/pubmed/30705718
http://dx.doi.org/10.4254/wjh.v11.i1.50

Ejemplares similares